<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, or <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined esophagus</z:e> (CLE), is a premalignant disorder in which the stratified squamous epithelium is replaced by metaplastic epithelium </plain></SENT>
<SENT sid="1" pm="."><plain>To gain more insight into the process of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in CLE, we studied several factors involved in the apoptotic pathway in biopsies with <z:mp ids='MP_0005213'>gastric metaplasia</z:mp> (GM), <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM), <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and/or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemistry was performed for Fas, Bcl-2, Bax, Bcl-xl, inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), and cyclooxygenase 2 (COX-2) </plain></SENT>
<SENT sid="3" pm="."><plain>Fas staining was positive in the epithelium of <z:hpo ids='HP_0000001'>all</z:hpo> biopsies from patients with CLE but negative in <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>Fas staining was positive in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of the 8 cases containing <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Bcl-2 was positive in lamina propria immune cells of <z:hpo ids='HP_0000001'>all</z:hpo> specimens </plain></SENT>
<SENT sid="6" pm="."><plain>Bax staining was positive in the epithelium of <z:hpo ids='HP_0000001'>all</z:hpo> biopsies, including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Bcl-xl was positive in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, but negative in 8 of 17 biopsies containing IM </plain></SENT>
<SENT sid="8" pm="."><plain>iNOS was positive in 20 of 21 biopsies with IM and in 4 of 8 <z:mpath ids='MPATH_589'>dysplasia</z:mpath> biopsies </plain></SENT>
<SENT sid="9" pm="."><plain>COX-2 was positive in 7 of 8 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that the apoptotic balance in the transformation from IM to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> switches to an antiapoptotic phenotype because of increased Bcl-xl expression and decreased Bax expression </plain></SENT>
<SENT sid="11" pm="."><plain>Fas can be used as a marker for the differentiation of gastric mucosa and <z:mpath ids='MPATH_160'>metaplasia</z:mpath> in the esophagus </plain></SENT>
<SENT sid="12" pm="."><plain>iNOS is highly positive in CLE-associated <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="13" pm="."><plain>COX-2 is negative in nonmalignant CLE </plain></SENT>
<SENT sid="14" pm="."><plain>Therefore, pharmacologic inhibition of COX-2 activity is unlikely to be effective in the preventing CLE-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="15" pm="."><plain>There was no clear correlation between iNOS expression and activation of proapoptotic and antiapoptotic genes </plain></SENT>
</text></document>